Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study

Real-world data regarding the effectiveness and safety of generic sofosbuvir (SOF)-based interferon-free direct acting antiviral agents (DAAs) for patients with chronic hepatitis C virus (HCV) infection remain limited. A total of 517 chronic HCV-infected patients receiving 12 or 24 weeks of SOF-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen-Hua, Huang, Yi-Jie, Yang, Sien-Sing, Chang, Chung-Hsin, Yang, Sheng-Shun, Sun, Hsin-Yun, Liu, Chun-Jen, Liu, Wen-Chun, Su, Tung-Hung, Yang, Hung-Chih, Hong, Chun-Ming, Tseng, Tai-Chung, Chen, Pei-Jer, Chen, Ding-Shinn, Hung, Chien-Ching, Kao, Jia-Horng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135833/
https://www.ncbi.nlm.nih.gov/pubmed/30209349
http://dx.doi.org/10.1038/s41598-018-32060-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135833/
https://www.ncbi.nlm.nih.gov/pubmed/30209349
http://dx.doi.org/10.1038/s41598-018-32060-7

Ejemplares similares